| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C22H22Cl3N3O |
| Molar mass | 450.79 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
O-1269 is a drug that is a diarylpyrazole derivative, related to potentcannabinoid antagonist drugs such asrimonabant andsurinabant. However O-1269 and several related drugs were unexpectedly found to act as full orpartial agonists at thecannabinoid receptors rather than antagonists, and so produce the usual effects expected of cannabinoid agonists in animal tests, such assedation andanalgesic effects. TheN-heptylhomolog O-1270 and theN-propyl homolog O-1399 also act as cannabinoid agonists with similar potencyin vivo, despite weaker binding affinity at cannabinoid receptors compared to the pentyl homolog O-1269.[1][2][3] Agonist-like and atypical cannabinoid activity has also been observed with a number of related compounds.[4][5]
Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it. |